Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Losch‐Beridon, T."'
Autor:
Benninga MA; Department of Paediatric Gastroenterology & Nutrition, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, the Netherlands., Hussain SZ; Willis-Knighton Pediatric Gastroenterology and Research, Shreveport, Louisiana., Sood MR; Division of Pediatric Gastroenterology, Children's Hospital of Wisconsin, Milwaukee, Wisconsin., Nurko S; Center for Motility and Functional Gastrointestinal Disorders, Boston Children's Hospital, Boston, Massachusetts., Hyman P; Gastroenterology Department, Children's Hospital, New Orleans, Louisiana., Clifford RA; Coastal Pediatric Associates, Charleston, South Carolina., O'Gorman M; Primary Children's Hospital, University of Utah, Salt Lake City, Utah., Losch-Beridon T; Clinical Development, Sucampo Pharmaceuticals, Rockville, Maryland., Mareya S; Clinical Program Management, Sucampo Pharmaceuticals, Rockville, Maryland., Lichtlen P; Sucampo AG, Zug, Switzerland., Di Lorenzo C; Division of Pediatric Gastroenterology, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: carlo.dilorenzo@nationwidechildrens.org.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Mar; Vol. 20 (3), pp. 602-610.e5. Date of Electronic Publication: 2021 Apr 07.
Autor:
Adams A; AB Clinical Trials, Las Vegas, NV, USA., Barish C; Wake Research Associates, Raleigh, NC, USA.; UNC School of Medicine, Chapel Hill, NC, USA., Chen A; Mallinckrodt Pharmaceuticals, Inc., Rockville, MD, USA., Dennis P; Delricht Research, New Orleans, LA, USA., Krause R; WR-Clinsearch, Chattanooga, TN, USA., Lichtlen P; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Zug, Switzerland., Losch-Beridon T; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Rockville, MD, USA., Mareya S; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Rockville, MD, USA., Schneider J; Precision Clinical Research, Sunrise, FL, USA. jschneider@pcrflorida.com.
Publikováno v:
Advances in therapy [Adv Ther] 2021 Jun; Vol. 38 (6), pp. 2936-2952. Date of Electronic Publication: 2021 Apr 08.
Autor:
Adams A; AB Clinical Trials, Las Vegas, NV, USA., Barish C; Wake Research Associates, Raleigh, NC, USA.; UNC School of Medicine, Chapel Hill, NC, USA., Chen A; Mallinckrodt Pharmaceuticals, Inc., Rockville, MD, USA., Dennis P; Delricht Research, New Orleans, LA, USA., Krause R; WR-Clinsearch, Chattanooga, TN, USA., Lichtlen P; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Zug, Switzerland., Losch-Beridon T; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Rockville, MD, USA., Mareya S; Sucampo Pharmaceuticals (a Legal Entity of Mallinckrodt Pharmaceuticals), Rockville, MD, USA., Schneider J; Precision Clinical Research, Sunrise, FL, USA. jschneider@pcrflorida.com.
Publikováno v:
Advances in therapy [Adv Ther] 2021 Jun; Vol. 38 (6), pp. 2953.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Autor:
Webster LR; PRA Health Sciences, Salt Lake City, Utah, USA., Brewer RP; River Cities Clinical Research Center, Shreveport, Louisiana, USA., Lichtlen P; Sucampo AG, Zug, Switzerland., Losch-Beridon T; Sucampo Pharmaceuticals, Inc., Rockville, Maryland, USA., Mareya S; Sucampo Pharmaceuticals, Inc., Rockville, Maryland, USA., Wang M; Sucampo Pharmaceuticals, Inc., Rockville, Maryland, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2018 Jun 01; Vol. 19 (6), pp. 1195-1205.
Autor:
Spierings ELH; Headache and Face Pain Program, Tufts Medical Center, and Craniofacial Pain Center, Tufts University School of Dental Medicine, Boston, Massachusetts, USA., Drossman DA; University of North Carolina at Chapel Hill, and Drossman Gastroenterology, Chapel Hill, North Carolina, USA., Cryer B; University of Texas Southwestern Medical School, Dallas, Texas, USA., Mazen Jamal M; Long Beach VA Medical Center, Long Beach, California, USA., Losch-Beridon T; Sucampo Pharma Americas, LLC, Rockville, Maryland, USA., Mareya SM; Sucampo Pharma Americas, LLC, Rockville, Maryland, USA., Wang M; Sucampo Pharma Americas, LLC, Rockville, Maryland, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2018 Jun 01; Vol. 19 (6), pp. 1184-1194.
Autor:
Turner-Bowker, D.M., Lindner, E., Mareya, S., Losch-Beridon, T., Elash, C.A., Paty, J., Keithly, S., Ascoytia, C.
Publikováno v:
In Value in Health May 2015 18(3):A28-A28
Autor:
Spierings EL; Headache & Face Pain Program, Tufts Medical Center, and Craniofacial Pain Center, Tufts University School of Dental Medicine, Boston, Massachusetts, U.S.A., Brewer RP; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, U.S.A., Rauck RL; Carolinas Pain Institute, Winston-Salem, North Carolina, U.S.A., Losch-Beridon T; Sucampo Pharma Americas, LLC, Bethesda, Maryland, U.S.A., Mareya SM; Sucampo Pharma Americas, LLC, Bethesda, Maryland, U.S.A.
Publikováno v:
Pain practice : the official journal of World Institute of Pain [Pain Pract] 2017 Mar; Vol. 17 (3), pp. 312-319. Date of Electronic Publication: 2016 Mar 15.
Publikováno v:
In Value in Health November 2014 17(7):A371-A371
Autor:
Hatswell AJ; BresMed, Sheffield, UK., Griffiths A; Research Economics, Solihull, UK., Lichtlen P; Sucampo, Zug, Switzerland., Losch-Beridon T; Sucampo Pharma Americas, Bethesda, MD, USA., Pennington B; BresMed, Sheffield, UK.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A371. Date of Electronic Publication: 2014 Oct 26.